5 Key Takeaways

• 1

  Poor metabolite identification in metabolomics leads to implausible compound assignments and insufficiently validated results.

• 2

  The rise of LC-MS technology has generated vast datasets but exposed weaknesses in data interpretation and metabolite identification.

• 3

  Misidentified metabolites can distort biological interpretations and influence future studies, databases, and clinical hypotheses.

• 4

  There is a critical need for stronger validation practices and awareness of best practices to ensure reliable metabolomics findings.

• 5

  Improving transparency and validation in metabolomics research is essential to prevent the propagation of errors in scientific literature.